we aimed to screen for pompe disease in patients with unclassified limb-girdle muscular dystrophy (lgmd) or asymptomatic hyperckemia using dried blood spot (dbs) assays.
We aimed to calculate the diagnostic delay between initial symptom presentation and the diagnosis.